Assessment of CLPP gene and protein show high expression in diffuse gliomas and other aggressive pediatric cancers (Figure 1B and C), highlighting the clinical potential of ClpP agonists.51,56 Development of new selective ClpP agonists, including the TR compounds, may add additional weapons to the barren armory of options we currently have for the treatment of DMG. Here, CLPP is linked to cancer.